Clinical Trial Update: Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications [Phase 4]

View source ↗

Summary

This is an ongoing Phase 4 trial evaluating Zavegepant for acute treatment of migraine in patients on CGRP preventive medications, focusing on effectiveness and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• Zavegepant (zavegepant)

Snippet

Sponsor: Mayo Clinic | Conditions: Migraine | Phase 4 | Status: RECRUITING